Follow-up of a French national cohort of melanoma stage IV and unresectable stage III patients, MelBase.

被引：0
|
作者：
Allayous, Clara
Dalle, Stephane
Saiag, Philippe
Dutriaux, Caroline
Mortier, Laurent
Dupuy, Alain
Lesimple, Thierry
Bahadoran, Philippe
Dalac, Sophie
Marie-Beylot-Barry
Maubec, Eve
Stoebner, Pierre-Emmanuel
Aubin, Francois
Arnault, Jean-Philippe
Verneuil, Laurence
Dreno, Brigitte
Kowal, Anita
Porcher, Raphael
Leccia, Marie Therese
Lebbe, Celeste
机构：
[1] Hop St Louis, Paris, France
[2] Univ Lyon, Canc Res Ctr Lyon, Pierre Benite, France
[3] Hosp Ambroise Pare, Boulogne, France
[4] CHU Bordeaux, Hop St Andre, Bordeaux, France
[5] CHRU Lille, F-59037 Lille, France
[6] CHU Rennes, Ctr Oncodermatol CLCC, Rennes, France
[7] Hop Archet, Nice, France
[8] CHU Dijon Dermatol, Dijon, France
[9] CHU Bordeaux Dermatol, Bordeaux, France
[10] Hop Bichat Claude Bernard, F-75877 Paris, France
[11] CHU Nimes, Dermatol, Nimes, France
[12] CHU Besancon, Dermatol, F-25030 Besancon, France
[13] CHU Amiens Dermatol, Amiens, France
[14] CHU Caen, Dermatol, F-14000 Caen, France
[15] CHU Nantes, Hotel Dieu, F-44035 Nantes 01, France
[16] Univ Paris 07, Informat Hop St Louis Biostat, AP HP, Paris, France
[17] Univ Paris 07, AP HP, Biostat, Paris, France
[18] CHU Grenoble, Dermatol, F-38043 Grenoble, France
[19] Hop St Louis, AP HP, Dept Dermatol, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20113
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MelBase, a French national cohort dedicated to melanoma unresectable stage III and IV patients
    Dalle, S.
    Mortier, L.
    Dutriaux, C.
    Dalac, S.
    Leccia, M.
    Saiag, P.
    Dreno, B.
    Kowal, A.
    Allayous, C.
    Lebbe, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S246 - S246
  • [2] Immunotherapy-treated melanoma brain metastases within the French national cohort. MelBase.
    Allayous, Clara
    Dalle, Stephane
    Lacour, Jean-Philippe
    Mortier, Laurent
    Dutriaux, Caroline
    Saiag, Philippe
    Dalac, Sophie
    Aubin, Francois
    Maubec, Eve
    Marie-Beylot-Barry
    Lesimple, Thierry
    Arnault, Jean-Philippe
    De Quatrebarbes, Julie
    Stoebner, Pierre-Emmanuel
    Dreno, Brigitte
    Chami, Ichrak
    Porcher, Raphael
    Kowal, Anita
    Leccia, Marie Therese
    Lebbe, Celeste
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] TREATMENT PATTERNS AND OUTCOMES IN THE FRENCH COHORT OF PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA (MELODY STUDY): A RETROSPECTIVE LONGITUDINAL SURVEY
    Bedane, C.
    Leccia, M. T.
    Sassolas, B.
    Mansard, S.
    Guillot, B.
    Mortier, L.
    Robert, C.
    Saiag, P.
    Truchetet, F.
    Oukessou, A.
    Bregman, B.
    Lebbe, C.
    VALUE IN HEALTH, 2010, 13 (07) : A273 - A273
  • [4] The cost of unresectable stage III or stage IV melanoma in Italy
    Michele Maio
    Paolo Ascierto
    Alessandro Testori
    Ruggero Ridolfi
    Emilio Bajetta
    Paola Queirolo
    Michele Guida
    Antonella Romanini
    Vanna Chiarion-Sileni
    Jacopo Pigozzo
    Anna Maria Di Giacomo
    Mario Calandriello
    Guido Didoni
    Marck van Baardewijk
    Cyril Konto
    Carlo Lucioni
    Journal of Experimental & Clinical Cancer Research, 31
  • [5] The cost of unresectable stage III or stage IV melanoma in Italy
    Maio, Michele
    Ascierto, Paolo
    Testori, Alessandro
    Ridolfi, Ruggero
    Bajetta, Emilio
    Queirolo, Paola
    Guida, Michele
    Romanini, Antonella
    Chiarion-Sileni, Vanna
    Pigozzo, Jacopo
    Di Giacomo, Anna Maria
    Calandriello, Mario
    Didoni, Guido
    van Baardewijk, Marck
    Konto, Cyril
    Lucioni, Carlo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [6] The interest of radiological follow-up for stage III melanoma
    Kerob, D
    Baccard, M
    Dupuy, A
    Olliveau, L
    Basset-Seguin, N
    Rybojad, M
    Schartz, NE
    Zagdanski, AM
    Dubertret, L
    Morel, P
    Lebbe, C
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2003, 130 (8-9): : 739 - 741
  • [7] TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA IN MEXICO
    Silva, A.
    Lazaro-Leon, M.
    de la Pena, R.
    Frausto, P.
    Vargas-Valencia, J. J.
    Gomez-Roel, X.
    Juarez-Garcia, A.
    Donato, B. M. K.
    Martinez-Rivera, G.
    Hernandez-Rivera, G.
    VALUE IN HEALTH, 2012, 15 (04) : A234 - A234
  • [8] A phase I trial of ipilimumab plus bevacizumab in patients with unresectable stage III or stage IV melanoma
    Hodi, F. S.
    Friedlander, P. A.
    Atkins, M. B.
    McDermott, D. F.
    Lawrence, D. P.
    Ibrahim, N.
    Wu, X.
    Zhou, J.
    Giobbie-Hurder, A.
    Murphy, G.
    Hollman, T.
    Velazquez, E.
    Russell, S.
    Dipiro, P.
    Yap, J. T.
    Van den Abbeele, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Follow-up of laparoscopic treatment of stage III-IV endometriosis
    Busacca, M
    Bianchi, S
    Agnoli, B
    Candiani, M
    Calia, C
    De Marinis, S
    Vignali, M
    JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 1999, 6 (01): : 55 - 58
  • [10] Individualizing Follow-Up for Patients With Early-Stage Melanoma
    Sondak, Vernon K.
    Leachman, Sancy A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (35) : 4606 - 4608
12345